Clinical Trial Update: rTSST-1 Variant Vaccine Phase 1 First-in-man Trail [Phase 1]

View source ↗

Summary

This update reports the completion of a Phase 1 first-in-man trial of an rTSST-1 variant vaccine intended to prevent toxic shock syndrome and sepsis, with resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sepsis
• Toxic Shock Syndrome

Drugs mentioned

• rTSST-1 Variant Vaccine (rTSST-1 variant vaccine)

Snippet

Sponsor: Biomedizinische Forschungs gmbH | Conditions: Toxic Shock Syndrome, Vaccination; Sepsis | Phase 1 | Status: COMPLETED | Results posted: 2017-01-31